Precigen
PGEN
133 hedge funds and large institutions have $84.8M invested in Precigen in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 19 closing their positions.
4,980% more call options, than puts
Call options by funds: $254K | Put options by funds: $5K
50% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 28
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
18% more capital invested
Capital invested by funds: $71.7M → $84.8M (+$13M)
5% more funds holding
Funds holding: 127 → 133 (+6)
0.3% less ownership
Funds ownership: 26.19% → 25.88% (-0.3%)
Top Buyers
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$676K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$474K |
| 3 |
Renaissance Technologies
New York
|
-$454K |
| 4 |
MP
MSD Partners
New York
|
-$336K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$327K |
PGEN Hedge Fund Activity: Q4 2024 in Review
133 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q4 2024, worth a combined $84.8M — up 18% from $71.7M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new PGEN positions and 19 closed out — a net gain of 7 holders — while 42 added to existing stakes and 28 trimmed.
The largest buyer was Iridian Asset Management, adding an estimated $1.25M. The largest seller was D.E. Shaw & Co, cutting an estimated $676K.
- 133 institutional investors held Precigen (PGEN) as of Q4 2024, up from 127 in Q3 2024.
- Funds reported $84.8M of Precigen stock for Q4 2024, up 18% quarter-over-quarter.
- 26 funds opened new Precigen positions in Q4 2024 and 19 closed out, a net change of +7 holders.
- The largest Precigen buyer in Q4 2024 was Iridian Asset Management, an estimated $1.25M added.
- The largest Precigen seller in Q4 2024 was D.E. Shaw & Co, an estimated $676K sold.
Based on aggregated 13F filings for Q4 2024.